These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 39072289)

  • 1. High CIB1 expression in colorectal cancer liver metastases correlates with worse survival and the replacement histopathological growth pattern.
    Fan S; Fleischer JR; Dokshokova L; Böhme LS; Haas G; Schmitt AM; Gätje FB; Rosen LE; Bohnenberger H; Ghadimi M; Cui B; Xu X; Kalucka JM; Bösch F; De Oliveira T; Conradi LC
    Mol Ther Oncol; 2024 Sep; 32(3):200828. PubMed ID: 39072289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different Forms of Tumor Vascularization and Their Clinical Implications Focusing on Vessel Co-option in Colorectal Cancer Liver Metastases.
    Haas G; Fan S; Ghadimi M; De Oliveira T; Conradi LC
    Front Cell Dev Biol; 2021; 9():612774. PubMed ID: 33912554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophils expressing lysyl oxidase-like 4 protein are present in colorectal cancer liver metastases resistant to anti-angiogenic therapy.
    Palmieri V; Lazaris A; Mayer TZ; Petrillo SK; Alamri H; Rada M; Jarrouj G; Park WY; Gao ZH; McDonald PP; Metrakos P
    J Pathol; 2020 Jun; 251(2):213-223. PubMed ID: 32297656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CIB1 correlates with colorectal liver metastases but not with peritoneal carcinomatosis.
    Jacob S; Bösch F; Schoenberg MB; Pretzsch E; Lampert C; Haoyu R; Renz BW; Michl M; Kumbrink J; Kirchner T; Werner J; Angele MK; Neumann J
    BMC Cancer; 2021 Nov; 21(1):1243. PubMed ID: 34794407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular differences of angiogenic versus vessel co-opting colorectal cancer liver metastases at single-cell resolution.
    Fleischer JR; Schmitt AM; Haas G; Xu X; Zeisberg EM; Bohnenberger H; Küffer S; Teuwen LA; Karras PJ; Beißbarth T; Bleckmann A; Planque M; Fendt SM; Vermeulen P; Ghadimi M; Kalucka J; De Oliveira T; Conradi LC
    Mol Cancer; 2023 Jan; 22(1):17. PubMed ID: 36691028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International consensus guidelines for scoring the histopathological growth patterns of liver metastasis.
    van Dam PJ; van der Stok EP; Teuwen LA; Van den Eynden GG; Illemann M; Frentzas S; Majeed AW; Eefsen RL; Coebergh van den Braak RRJ; Lazaris A; Fernandez MC; Galjart B; Laerum OD; Rayes R; Grünhagen DJ; Van de Paer M; Sucaet Y; Mudhar HS; Schvimer M; Nyström H; Kockx M; Bird NC; Vidal-Vanaclocha F; Metrakos P; Simoneau E; Verhoef C; Dirix LY; Van Laere S; Gao ZH; Brodt P; Reynolds AR; Vermeulen PB
    Br J Cancer; 2017 Nov; 117(10):1427-1441. PubMed ID: 28982110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathological Growth Patterns Determine the Outcomes of Colorectal Cancer Liver Metastasis Following Liver Resection.
    Krzywoń L; Lazaris A; Petrillo SK; Zlotnik O; Gao ZH; Metrakos P
    Cancers (Basel); 2024 Sep; 16(18):. PubMed ID: 39335120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical implications and mechanism of histopathological growth pattern in colorectal cancer liver metastases.
    Kong BT; Fan QS; Wang XM; Zhang Q; Zhang GL
    World J Gastroenterol; 2022 Jul; 28(26):3101-3115. PubMed ID: 36051338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptomic characterization of the histopathological growth patterns in breast cancer liver metastases.
    Leduc S; Nguyen HL; Richard F; Zels G; Mahdami A; De Schepper M; Maetens M; Pabba A; Jaekers J; Latacz E; Bohlok A; Vanderheyden E; Van Brussel T; Boeckx B; Schepers R; Lambrechts D; Dirix L; Larsimont D; Vankerckhove S; Lucidi V; Topal B; Bachir I; Donckier V; Floris G; Vermeulen P; Desmedt C
    Clin Exp Metastasis; 2024 Oct; 41(5):699-705. PubMed ID: 38548918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathological growth patterns of neuroendocrine tumor liver metastases.
    Meyer Y; Bohlok A; Olthof P; Donckier V; Doukas M; Lucidi V; Vermeulen P; Grünhagen D; Verhoef C
    Clin Exp Metastasis; 2023 Jun; 40(3):227-234. PubMed ID: 37183203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replacement and desmoplastic histopathological growth patterns in cutaneous melanoma liver metastases: frequency, characteristics, and robust prognostic value.
    Barnhill R; van Dam PJ; Vermeulen P; Champenois G; Nicolas A; Rawson RV; Wilmott JS; Thompson JF; Long GV; Cassoux N; Roman-Roman S; Busam KJ; Scolyer RA; Lazar AJ; Lugassy C
    J Pathol Clin Res; 2020 Jul; 6(3):195-206. PubMed ID: 32304183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenic desmoplastic histopathological growth pattern as a prognostic marker of good outcome in patients with colorectal liver metastases.
    Galjart B; Nierop PMH; van der Stok EP; van den Braak RRJC; Höppener DJ; Daelemans S; Dirix LY; Verhoef C; Vermeulen PB; Grünhagen DJ
    Angiogenesis; 2019 May; 22(2):355-368. PubMed ID: 30637550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Retrospective Study on the Role of Metformin in Colorectal Cancer Liver Metastases.
    Rada M; Krzywon L; Petrillo S; Lazaris A; Metrakos P
    Biomedicines; 2023 Feb; 11(3):. PubMed ID: 36979711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between primary tumor characteristics and histopathological growth pattern of liver metastases in colorectal cancer.
    Bohlok A; Tonneau C; Vankerckhove S; Craciun L; Lucidi V; Bouazza F; Hendlisz A; Van Laethem JL; Larsimont D; Vermeulen P; Donckier V; Demetter P
    Clin Exp Metastasis; 2023 Oct; 40(5):431-440. PubMed ID: 37453024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HMGA1 Promotes Hepatic Metastasis of Colorectal Cancer by Inducing Expression of Glucose Transporter 3 (GLUT3).
    Yang M; Guo Y; Liu X; Liu N
    Med Sci Monit; 2020 Sep; 26():e924975. PubMed ID: 32989212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential histopathologic parameters in colorectal cancer liver metastases resected after triplets plus bevacizumab or cetuximab: a pooled analysis of five prospective trials.
    Cremolini C; Milione M; Marmorino F; Morano F; Zucchelli G; Mennitto A; Prisciandaro M; Lonardi S; Pellegrinelli A; Rossini D; Bergamo F; Aprile G; Urbani L; Morelli L; Schirripa M; Cardellino GG; Fassan M; Fontanini G; de Braud F; Mazzaferro V; Falcone A; Pietrantonio F
    Br J Cancer; 2018 Apr; 118(7):955-965. PubMed ID: 29531324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of histopathological growth pattern in predicting 3-year progression free survival after operation in patients with liver metastasis of colorectal cancer].
    Zhang YL; He HJ; Cheng J; Shen DH
    Zhonghua Bing Li Xue Za Zhi; 2021 Jan; 50(1):26-31. PubMed ID: 33396983
    [No Abstract]   [Full Text] [Related]  

  • 18. Replacement and desmoplastic histopathological growth patterns: A pilot study of prediction of outcome in patients with uveal melanoma liver metastases.
    Barnhill R; Vermeulen P; Daelemans S; van Dam PJ; Roman-Roman S; Servois V; Hurbain I; Gardrat S; Raposa G; Nicolas A; Dendale R; Pierron G; Desjardins L; Cassoux N; Piperno-Neumann S; Mariani P; Lugassy C
    J Pathol Clin Res; 2018 Oct; 4(4):227-240. PubMed ID: 29917326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathological growth pattern of liver metastases as an independent marker of metastatic behavior in different primary cancers.
    Bohlok A; Richard F; Lucidi V; Asmar AE; Demetter P; Craciun L; Larsimont D; Hendlisz A; Van Laethem JL; Dirix L; Desmedt C; Vermeulen P; Donckier V
    Front Oncol; 2023; 13():1260880. PubMed ID: 37965465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathological growth pattern evolution of tumor in VX2 liver cancer model.
    Kong B; Zhou J; Wang H; Li Y; Pan Y; Zhu H; Zhang Q; Fan Q; Wang X; Zhang G
    Pathol Res Pract; 2023 Apr; 244():154401. PubMed ID: 36905696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.